The American Academy of Orthopaedic Surgeons noted at their annual meeting in March that research indicates a significant correlation between heart disease in men and the ASR XL hip prosthesis by DePuy. Researchers used the Australian Government Department of Veterans Affairs database and studied over 2,000 men who had received a metal-on-polyethylene (MoP) hip implant. The study indicated that men who had received the ASR XL hip implant (DePuy Synthes Joint Reconstruction) had a significantly higher rate of hospitalisation for heart failure. Stephen Graves, MD, who spoke at the meeting regarding the study, noted that “As far as we are aware, this is the first cohort study to indicate an association with heart failure the use of the ASR XL prosthesis. The effect was evident in men. We were able to quantify the incidence in the study population, and the incidence was not small”. The study found that there was one additional heart failure incident for every ten patients treated with the ASR XL implant.
In 2008, Maglio Christopher & Toale, P.A. Law Firm filed the first lawsuit in the United States against a manufacturer of the current generation of defective metal on metal hip replacements. Ever since then, we have aggressively litigated against the makers of these defective medical devices across the United States. For more information about defective hip implants, please visit our defective joint replacement page.